High prevalence of significant heart valve lesions in patients with the 'primary' antiphospholipid syndrome
- PMID: 1845363
- DOI: 10.1177/096120339100100108
High prevalence of significant heart valve lesions in patients with the 'primary' antiphospholipid syndrome
Abstract
A prospective echocardiographic study was carried out on 55 patients with the recently described 'primary' antiphospholipid syndrome derived from three university medical centres. The prevalence of valvular lesions in patients with this syndrome was 38% compared with 4% in a control group of 55 healthy volunteers (P < 0.001). Mean age of patients with valve abnormalities was 42 +/- 12 years and of those without, 30 +/- 10 years (P < 0.05). One patient had a morphologic echocardiographic pattern suggestive of non-infective verrucous mitral endocarditis. Twenty patients had a two-dimensional or Doppler echocardiographic pattern of significant valvular dysfunction--either regurgitation or stenosis--without evidence of vegetations. Mitral and aortic regurgitation were the most common lesions in these patients. During follow-up of patients with valvular disease, haemodynamically significant clinical valve disease developed in four and surgery was required in one. Eleven patients had cerebrovascular occlusions. Thus, valvular heart disease, particularly affecting the mitral and aortic valves, is common in patients with the 'primary' antiphospholipid syndrome, especially in those over 40 years old.
Similar articles
-
Valvular heart disease in the primary antiphospholipid syndrome.Ann Intern Med. 1992 Feb 15;116(4):293-8. doi: 10.7326/0003-4819-116-4-293. Ann Intern Med. 1992. PMID: 1733383
-
[Heart valve involvement in systemic lupus erythematosus: an echocardiographic study].G Ital Cardiol. 1992 Nov;22(11):1301-8. G Ital Cardiol. 1992. PMID: 1297616 Italian.
-
[Valvulopathy in primary antiphospholipid syndrome. Prospective echocardiography study].Gac Med Mex. 2000 Jan-Feb;136(1):3-8; discussion 9. Gac Med Mex. 2000. PMID: 10721593 Spanish.
-
Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome.Circulation. 1996 Apr 15;93(8):1579-87. doi: 10.1161/01.cir.93.8.1579. Circulation. 1996. PMID: 8608627 Review.
-
[The best of valvular heart disease in 2006].Arch Mal Coeur Vaiss. 2007 Jan;100 Spec No 1:19-28. Arch Mal Coeur Vaiss. 2007. PMID: 17405561 Review. French.
Cited by
-
Near complete resolution of nonbacterial thrombotic endocarditis in a patient with antiphospholipid antibody syndrome.Anatol J Cardiol. 2020 Aug;24(2):E5-E7. doi: 10.14744/AnatolJCardiol.2020.33027. Anatol J Cardiol. 2020. PMID: 32749246 Free PMC article. No abstract available.
-
Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases.Front Med (Lausanne). 2018 Feb 14;5:26. doi: 10.3389/fmed.2018.00026. eCollection 2018. Front Med (Lausanne). 2018. PMID: 29497612 Free PMC article. Review.
-
Complete Resolution of a Large Bicuspid Aortic Valve Thrombus with Anticoagulation in Primary Antiphospholipid Syndrome.Front Cardiovasc Med. 2017 Sep 20;4:59. doi: 10.3389/fcvm.2017.00059. eCollection 2017. Front Cardiovasc Med. 2017. PMID: 28979899 Free PMC article.
-
Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome.Ann Rheum Dis. 2005 Oct;64(10):1490-3. doi: 10.1136/ard.2004.032813. Epub 2005 Mar 18. Ann Rheum Dis. 2005. PMID: 15778242 Free PMC article.
-
The antiphospholipid syndrome.J R Coll Physicians Lond. 1994 Jul-Aug;28(4):301-4. J R Coll Physicians Lond. 1994. PMID: 7965966 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical